34. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, et al. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405: 360–364. 35. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, et al. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegen- eration. Nature 402: 615–622. 36. Li BS, Ma W, Jaffe H, Zheng Y, Takahashi S, et al. (2003) Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J Biol Chem 278: 35702– 35709. 37. Li BS, Zhang L, Takahashi S, Ma W, Jaffe H, et al. (2002) Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. Embo J 21: 324–333. 38. Takahashi S, Ohshima T, Hirasawa M, Pareek TK, Bugge TH, et al. (2010) Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration. Am J Pathol 176: 320–329. 39. Cheung ZH, Gong K, Ip NY (2008) Cyclin-dependent kinase 5 supports neuronal survival through phosphorylation of Bcl-2. J Neurosci 28: 4872–4877. 40. Wang CX, Song JH, Song DK, Yong VW, Shuaib A, et al. (2006) Cyclin- dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2. Cell Death Differ 13: 1203–1212. 41. Endo R, Saito T, Asada A, Kawahara H, Ohshima T, et al. (2009) Commitment of 1-methyl-4-phenylpyrinidinium ion-induced neuronal cell death by protea- some-mediated degradation of p35 cyclin-dependent kinase 5 activator. J Biol Chem 284: 26029–26039. REST Target Genes and Beta Cell Survival 42. Ubeda M, Rukstalis JM, Habener JF (2006) Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity. J Biol Chem 281: 28858–28864. 43. Daval M, Gurlo T, Costes S, Huang CJ, Butler PC (2011) Cyclin-Dependent Kinase 5 Promotes Pancreatic {beta}-Cell Survival via Fak-Akt Signaling Pathways. Diabetes 60: 1186–1197. 44. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, et al. (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54 Suppl 2: S97–107. 45. Trimble ER, Bruzzone R, Gjinovci A, Renold AE (1985) Activity of the insulo- acinar axis in the isolated perfused rat pancreas. Endocrinology 117: 1246–1252. 46. Martin D, Tawadros T, Meylan L, Abderrahmani A, Condorelli DF, et al. (2003) Critical role of the transcriptional repressor neuron-restrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines. J Biol Chem 278: 53082–53089. 47. Allagnat F, Martin D, Condorelli DF, Waeber G, Haefliger JA (2005) Glucose represses connexin36 in insulin-secreting cells. J Cell Sci 118: 5335–5344. 48. Brun T, Duhamel DL, Hu He KH, Wollheim CB, Gauthier BR (2007) The transcription factor PAX4 acts as a survival gene in INS-1E insulinoma cells. Oncogene 26: 4261–4271. 49. Allagnat F, Cunha D, Moore F, Vanderwinden JM, Eizirik DL, et al. (2011) Mcl-1 downregulation by pro-inflammatory cytokines and palmitate is an early event contributing to beta-cell apoptosis. Cell Death Differ 18: 328–337. PLOS ONE | www.plosone.org 11 September 2012 | Volume 7 | Issue 9 | e45844